Pharmaceutical sponsors 'eager to invest' in in-person meetings

Pharmaceutical and biopharma sponsors are eager to invest in face-to-face meetings as lust for online drops, according to a recent survey.

Congress organiser AIM Group International has released the results from the survey: Events in-person, hybrid or digital? Trends and perspectives from the Sponsors, which polled 200 representatives from pharmaceutical and biopharma companies.

The results revealed that half of the respondents are ready to sponsor in-person events next autumn and only 16 per cent exclude it as an option entirely.

As to be expected, 37 per cent said they would prefer to make the decision at a later date.

In contrast to online events held in 2020 and the beginning of 2021, 43 per cent of respondents indicated that the majority of event budgets for the remainder of this year will be for in-person or hybrid events.